Effect of IL-15 addition on asbestos-induced suppression of human cytotoxic T lymphocyte induction

April 27, 2021 | Comments Off on Effect of IL-15 addition on asbestos-induced suppression of human cytotoxic T lymphocyte induction

Environmental Health and Preventive Medicine 2021 [Link] Naoko Kumagai-Takei, Yasumitsu Nishimura, Hidenori Matsuzaki, Suni Lee, Kei Yoshitome, Tatsuo Ito, Takemi Otsuki Abstract Background: Asbestos fibers possess tumorigenicity and are thought…

Sulforaphane inhibits PRMT5 and MEP50 function to suppress the mesothelioma cancer cell phenotype

April 26, 2021 | Comments Off on Sulforaphane inhibits PRMT5 and MEP50 function to suppress the mesothelioma cancer cell phenotype

Molecular Carcinogenesis 2021 April 19 [Link] Geraldine Ezeka, Gautam Adhikary, Sivaveera Kandasamy, Joseph S Friedberg, Richard L Eckert Abstract Mesothelioma is a highly aggressive cancer of the mesothelial lining that…

Malignant pleural mesothelioma co-opts BCL-X L and autophagy to escape apoptosis

April 23, 2021 | Comments Off on Malignant pleural mesothelioma co-opts BCL-X L and autophagy to escape apoptosis

Cell Death & Disease 2021 April 15 [Link] Duo Xu, Shun-Qing Liang, Zhang Yang, Haitang Yang, Rémy Bruggmann, Simone Oberhaensli, Sabina Berezowska, Thomas M Marti, Sean R R Hall, Patrick…

Tertiary lymphoid structures in epithelioid malignant peritoneal mesothelioma are associated with neoadjuvant chemotherapy, but not with prognosis

April 22, 2021 | Comments Off on Tertiary lymphoid structures in epithelioid malignant peritoneal mesothelioma are associated with neoadjuvant chemotherapy, but not with prognosis

Virchows Archiv 2021 April 14 [Link] Nazim Benzerdjeb, Peggy Dartigues, Vahan Kepenekian, Séverine Valmary-Degano, Eliane Mery, Gerlinde Avérous, Anne Chevallier, Marie-Hélène Laverriere, Irène Villa, Olivier Harou, Françoise Galateau Sallé, Laurent…

L1CAM expression in cystic mesothelial lesions: a comparison with adenomatoid tumors, well-differentiated papillary mesothelial tumors and malignant mesotheliomas

April 21, 2021 | Comments Off on L1CAM expression in cystic mesothelial lesions: a comparison with adenomatoid tumors, well-differentiated papillary mesothelial tumors and malignant mesotheliomas

Histopathology 2021 April 13 [Link] Georgia Karpathiou, Francois Casteillo, Maroa Dridi, Alexandra Papoudou-Bai, Jean Marc Dumollard, Michel Peoc’h Abstract Malignant mesothelioma (MM), the primary cancer of the mesothelium, is characterized…

Malignant pleural mesothelioma: clinical experience and prognostic value of derived neutrophil-to-lymphocyte ratio and PD-L1 expression

April 20, 2021 | Comments Off on Malignant pleural mesothelioma: clinical experience and prognostic value of derived neutrophil-to-lymphocyte ratio and PD-L1 expression

Clinical and Translational Oncology 2021 April 10 [Link] L Gutierrez-Sainz, P Cruz, S Martinez-Recio, O Higuera, M I Esteban-Rodriguez, F Arias-Lotto, R A Gonzalez, J De Castro-Carpeño Abstract Background: Malignant…

Incidence of mesothelioma and asbestosis by occupation in a diverse workforce

April 19, 2021 | Comments Off on Incidence of mesothelioma and asbestosis by occupation in a diverse workforce

American Journal of Industrial Medicine 2021 April 8 [Link] Nathan L DeBono, Hunter Warden, Chloë Logar-Henderson, Sharara Shakik, Mamadou Dakouo, Jill MacLeod, Paul A Demers Abstract Objective: We sought to…

Malignant pleural mesothelioma: clinical experience and prognostic value of derived neutrophil-to-lymphocyte ratio and PD-L1 expression

April 16, 2021 | Comments Off on Malignant pleural mesothelioma: clinical experience and prognostic value of derived neutrophil-to-lymphocyte ratio and PD-L1 expression

Clinical and Translational Oncology 2021 April 10 [Link] L Gutierrez-Sainz, P Cruz, S Martinez-Recio, O Higuera, M I Esteban-Rodriguez, F Arias-Lotto, R A Gonzalez, J De Castro-Carpeño Abstract Background: Malignant…

P14/ARF-Positive Malignant Pleural Mesothelioma: A Phenotype With Distinct Immune Microenvironment

April 15, 2021 | Comments Off on P14/ARF-Positive Malignant Pleural Mesothelioma: A Phenotype With Distinct Immune Microenvironment

Frontiers in Oncology 2021 March 22 [Link] Federica Pezzuto, Francesca Lunardi, Luca Vedovelli, Francesco Fortarezza, Loredana Urso, Federica Grosso, Giovanni Luca Ceresoli, Izidor Kern, Gregor Vlacic, Eleonora Faccioli, Marco Schiavon,…

Premature phase II study of amrubicin as palliative chemotherapy for previously treated malignant pleural mesothelioma

April 14, 2021 | Comments Off on Premature phase II study of amrubicin as palliative chemotherapy for previously treated malignant pleural mesothelioma

Thoracic Cancer 2021 April 8 [Link] Kageaki Watanabe, Yusuke Okuma, Shoko Kawai, Makoto Nagamata, Yukio Hosomi Abstract Background: Treatment options for malignant pleural mesothelioma (MPM) are limited. Anthracyclines are considered…

Categories